| Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases JA Marrero, LM Kulik, CB Sirlin, AX Zhu, RS Finn, MM Abecassis, ... Hepatology 68 (2), 723-750, 2018 | 3954 | 2018 |
| AASLD guidelines for the treatment of hepatocellular carcinoma JK Heimbach, LM Kulik, RS Finn, CB Sirlin, MM Abecassis, LR Roberts, ... Hepatology 67 (1), 358-380, 2018 | 3774 | 2018 |
| Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy SB Reeder, I Cruite, G Hamilton, CB Sirlin Journal of magnetic resonance imaging 34 (4), 729-749, 2011 | 971 | 2011 |
| Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease R Loomba, V Seguritan, W Li, T Long, N Klitgord, A Bhatt, PS Dulai, ... Cell metabolism 25 (5), 1054-1062. e5, 2017 | 916 | 2017 |
| Nonalcoholic fatty liver disease EM Brunt, VWS Wong, V Nobili, CP Day, S Sookoian, JJ Maher, ... Nature reviews Disease primers 1 (1), 1-22, 2015 | 843 | 2015 |
| Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients V Chernyak, KJ Fowler, A Kamaya, AZ Kielar, KM Elsayes, MR Bashir, ... Radiology 289 (3), 816-830, 2018 | 804 | 2018 |
| Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty … CC Park, P Nguyen, C Hernandez, R Bettencourt, K Ramirez, L Fortney, ... Gastroenterology 152 (3), 598-607. e2, 2017 | 698 | 2017 |
| Decoding global gene expression programs in liver cancer by noninvasive imaging E Segal, CB Sirlin, C Ooi, AS Adler, J Gollub, X Chen, BK Chan, ... Nature biotechnology 25 (6), 675-680, 2007 | 669 | 2007 |
| In vivo characterization of the liver fat 1H MR spectrum G Hamilton, T Yokoo, M Bydder, I Cruite, ME Schroeder, CB Sirlin, ... NMR in Biomedicine 24 (7), 784-790, 2011 | 645 | 2011 |
| Heritability of nonalcoholic fatty liver disease JB Schwimmer, MA Celedon, JE Lavine, R Salem, N Campbell, ... Gastroenterology 136 (5), 1585-1592, 2009 | 575 | 2009 |
| Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials M Noureddin, J Lam, MR Peterson, M Middleton, G Hamilton, TA Le, ... Hepatology 58 (6), 1930-1940, 2013 | 559 | 2013 |
| Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis AN Tang, J Tan, M Sun, G Hamilton, M Bydder, T Wolfson, AC Gamst, ... Radiology 267 (2), 422-431, 2013 | 551 | 2013 |
| CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features JY Choi, JM Lee, CB Sirlin Radiology 273 (1), 30-50, 2014 | 534 | 2014 |
| Fatty liver: imaging patterns and pitfalls OW Hamer, DA Aguirre, G Casola, JE Lavine, M Woenckhaus, CB Sirlin Radiographics 26 (6), 1637-1653, 2006 | 534 | 2006 |
| Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration SB Reeder, HH Hu, CB Sirlin Journal of magnetic resonance imaging: JMRI 36 (5), 1011, 2012 | 518 | 2012 |
| Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study R Loomba, T Wolfson, B Ang, J Hooker, C Behling, M Peterson, ... Hepatology 60 (6), 1920-1928, 2014 | 514 | 2014 |
| CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects JY Choi, JM Lee, CB Sirlin Radiology 272 (3), 635-654, 2014 | 514 | 2014 |
| SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease JB Schwimmer, W Dunn, GJ Norman, PE Pardee, MS Middleton, N Kerkar, ... Gastroenterology 138 (4), 1357-1364. e2, 2010 | 510 | 2010 |
| LI‐RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions DG Mitchell, J Bruix, M Sherman, CB Sirlin Hepatology 61 (3), 1056-1065, 2015 | 507 | 2015 |
| Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease GI Smith, M Shankaran, M Yoshino, GG Schweitzer, M Chondronikola, ... The Journal of clinical investigation 130 (3), 1453-1460, 2020 | 498 | 2020 |
